Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Ling Chang

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Hepato-Gastroenterology|December 24, 2008
Dense packing of portal lymphocytes predicts favorable treatment outcome in hepatitis CMing-Ling Chang, Chao-Wei Hsu, Shiu-Feng Huang, et al.
BMC Medical Genomics|August 12, 2009
Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activationMing-Ling Chang, Chau-Ting Yeh, Deng-Yn Lin, et al.
International Journal of Cancer|August 21, 2013
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinomaChau-Ting Yeh, Kung-Hao Liang, Chen-Chun Lin, et al.
Therapeutic Advances in Gastroenterology|June 28, 2019
The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohortsChun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, et al.
Oncoimmunology|February 26, 2025
Mixed cryoglobulinemia decelerates hepatocellular carcinoma development in hepatitis C patients with SVR by downregulating regulatory B cells: a 12-year prospective cohort studyMing-Ling Chang, Jur-Shan Cheng, Wei-Ting Chen, et al.
Therapeutic Advances in Gastroenterology|April 1, 2024
Evolutionary relationship between antimitochondrial antibody positivity and primary biliary cholangitis in Taiwan: a 16-year hospital cohort studyMing-Ling Chang, Jur-Shan Cheng, Puo-Hsien Le, et al.
International Journal of Endocrinology|September 4, 2025
The Causal Mechanism Between the Dipeptidyl Peptidase-4, Heart Failure, and Other Cardiovascular Diseases: A Mendelian Randomization and Mediation StudyChe-Kai Chen, Chang-Fu Kuo, Yu-Jing Chang, et al.
Cancer Science|December 12, 2023
Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotypeJennifer Tai, Chao-Wei Hsu, Wei-Ting Chen, et al.
Scandinavian Journal of Gastroenterology|October 7, 2014
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control studyChih-Lang Lin, Rong-Nan Chien, Charisse Yeh, et al.
Diabetes, Obesity & Metabolism|April 30, 2024
Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3-year prospective cohort studyMing-Ling Chang, Jennifer Tai, Jur-Shan Cheng, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Hepato-Gastroenterology|December 24, 2008
Dense packing of portal lymphocytes predicts favorable treatment outcome in hepatitis CMing-Ling Chang, Chao-Wei Hsu, Shiu-Feng Huang, et al.
BMC Medical Genomics|August 12, 2009
Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activationMing-Ling Chang, Chau-Ting Yeh, Deng-Yn Lin, et al.
International Journal of Cancer|August 21, 2013
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinomaChau-Ting Yeh, Kung-Hao Liang, Chen-Chun Lin, et al.
Therapeutic Advances in Gastroenterology|June 28, 2019
The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohortsChun-Wei Chen, Jur-Shan Cheng, Tai-Di Chen, et al.
Oncoimmunology|February 26, 2025
Mixed cryoglobulinemia decelerates hepatocellular carcinoma development in hepatitis C patients with SVR by downregulating regulatory B cells: a 12-year prospective cohort studyMing-Ling Chang, Jur-Shan Cheng, Wei-Ting Chen, et al.
Therapeutic Advances in Gastroenterology|April 1, 2024
Evolutionary relationship between antimitochondrial antibody positivity and primary biliary cholangitis in Taiwan: a 16-year hospital cohort studyMing-Ling Chang, Jur-Shan Cheng, Puo-Hsien Le, et al.
International Journal of Endocrinology|September 4, 2025
The Causal Mechanism Between the Dipeptidyl Peptidase-4, Heart Failure, and Other Cardiovascular Diseases: A Mendelian Randomization and Mediation StudyChe-Kai Chen, Chang-Fu Kuo, Yu-Jing Chang, et al.
Cancer Science|December 12, 2023
Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotypeJennifer Tai, Chao-Wei Hsu, Wei-Ting Chen, et al.
Scandinavian Journal of Gastroenterology|October 7, 2014
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control studyChih-Lang Lin, Rong-Nan Chien, Charisse Yeh, et al.
Diabetes, Obesity & Metabolism|April 30, 2024
Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3-year prospective cohort studyMing-Ling Chang, Jennifer Tai, Jur-Shan Cheng, et al.
Pageof 16